These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Dissection of c-Mpl and thrombopoietin function: studies of knockout mice and receptor signal transduction. Gurney AL; de Sauvage FJ Stem Cells; 1996; 14 Suppl 1():116-23. PubMed ID: 11012211 [TBL] [Abstract][Full Text] [Related]
4. The structure, biology and potential therapeutic applications of recombinant thrombopoietin. Lok S; Foster DC Stem Cells; 1994 Nov; 12(6):586-98. PubMed ID: 7881359 [TBL] [Abstract][Full Text] [Related]
5. The impact of thrombopoietin and related Mpl-ligands on transfusion medicine. Farese AM; Schiffer CA; MacVittie TJ Transfus Med Rev; 1997 Oct; 11(4):243-55. PubMed ID: 9345706 [No Abstract] [Full Text] [Related]
6. Biologic effects of thrombopoietin, the Mpl ligand, and its therapeutic potential. Papayannopoulou T Cancer Chemother Pharmacol; 1996; 38 Suppl():S69-73. PubMed ID: 8765421 [TBL] [Abstract][Full Text] [Related]
11. The role of the MPL receptor in myeloproliferative disorders. Kaushansky K Leukemia; 1998 Sep; 12 Suppl 1():S47-50. PubMed ID: 9777896 [TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin (Mpl ligand) and the regulation of platelet production. Cohen-Solal K; Debili N; Vainchenker W; Wendling F Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371 [No Abstract] [Full Text] [Related]
13. Thrombopoietin: from theory to reality. Kaushansky K Thromb Haemost; 1999 Aug; 82(2):312-7. PubMed ID: 10605719 [No Abstract] [Full Text] [Related]
14. In vivo effects of Mpl ligand administration and emerging clinical applications for the Mpl ligands. Kuter DJ Curr Opin Hematol; 1997 May; 4(3):163-70. PubMed ID: 9209831 [TBL] [Abstract][Full Text] [Related]
15. Thrombopoietin and its receptor: structure, function and role in the regulation of platelet production. von dem Borne AE; Folman C; Linthorst GE; Porcelijn L; van den Oudenrijn S; van der Schoot E; de Haas M Baillieres Clin Haematol; 1998 Jun; 11(2):409-26. PubMed ID: 10097817 [No Abstract] [Full Text] [Related]
16. Tec protein-tyrosine kinase is involved in the thrombopoietin/c-Mpl signaling pathway. Yamashita Y; Miyazato A; Shimizu R; Komatsu N; Miura Y; Ozawa K; Mano H Exp Hematol; 1997 Mar; 25(3):211-6. PubMed ID: 9091296 [TBL] [Abstract][Full Text] [Related]
17. Thrombopoietin: expression of its receptor MPL and proliferative effects on leukemic cells. Drexler HG; Quentmeier H Leukemia; 1996 Sep; 10(9):1405-21. PubMed ID: 8751457 [TBL] [Abstract][Full Text] [Related]
18. The molecular and cellular biology of thrombopoietin: the primary regulator of platelet production. Kaushansky K; Drachman JG Oncogene; 2002 May; 21(21):3359-67. PubMed ID: 12032774 [TBL] [Abstract][Full Text] [Related]
19. A truncated isoform of c-Mpl with an essential C-terminal peptide targets the full-length receptor for degradation. Coers J; Ranft C; Skoda RC J Biol Chem; 2004 Aug; 279(35):36397-404. PubMed ID: 15210714 [TBL] [Abstract][Full Text] [Related]
20. Thrombopoietin and the humoral regulation of thrombocytopoiesis. Eaton DL; de Sauvage FJ Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]